Skip to main content

Audacity IB Wins 2025 Healthcare & Life Sciences Deal of the Year; To Be Honored at the 16th Annual International M&A Awards for Sale of ZyMōt Fertility to CooperSurgical

We are pleased to announce that Audacity IB will be honored by The M&A Advisor at the upcoming 16th annual International M&A Awards in Manhattan, New York for winning Healthcare & Life Sciences Deal of the Year (Under $100M).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827221276/en/

Audacity IB acted as exclusive sell-side financial advisor to ZyMōt Fertility in the sales of the Company to CooperSurgical

Audacity IB acted as exclusive sell-side financial advisor to ZyMōt Fertility in the sales of the Company to CooperSurgical

The recognition is for the sale of ZyMōt Fertility to CooperSurgical - see transaction announcement below. Audacity IB acted as exclusive financial advisor on the transaction. This is the second time in three years that Audacity IB has received this honor, after receiving the Private Equity Deal of the Year Award in the under $50 million category in 2023 for the sale of sustainable seafood company Lee Fish to Sole Source Capital.

The winners of the 16th Annual International M&A Awards will be honored at a prestigious Black-tie Gala, a key feature of the 2025 Leadership in Dealmaking Summit, to be held on September 15th & 16th in New York City. It will feature prominent deal makers, investors, and advisors participating in exclusive ‘M&A Ideas’ keynote conversations and fireside chats, and ‘M&A Connects’ 1-on-1 meetings.

“True excellence in dealmaking is defined by clarity of vision, bold leadership, and the ability to create lasting impact,” said Roger Aguinaldo, Founder & CEO of The M&A Advisor. “As the recipient of the Deal of the Year Award for Healthcare & Life Sciences in the below $100M category, Audacity IB exemplifies these qualities. We proudly celebrate Audacity IB for exceptional results, surpassing peers, and setting a new standard for success in today’s dynamic and competitive marketplace.”

“We are thrilled to be recognized again by The M&A Advisor, one of the most respected awards organizations in our industry. This honor underscores the significant work we have had the privilege of doing with founders during pivotal moments in their journeys. It is a reflection of our team’s relentless commitment to creativity, rigor, and impact. We are grateful to the clients and partners who place their trust in us, and we remain dedicated to standing shoulder-to-shoulder with founders as they navigate growth and transition,” said Jeffrey Shippy, Founder & CEO of Audacity IB.

AUDACITY IB ADVISES ON THE SALE OF ZYMŌT FERTILITY TO COOPERSURGICAL

Audacity IB, a nationally recognized boutique M&A investment bank and transaction consulting firm focused on founder-owned business transformations and exits, announced today that its client, ZyMōt Fertility (the “Company”), has been acquired by CooperSurgical.

ZyMōt Fertility is the world’s leading provider of proprietary sperm separation devices for assisted reproductive technology (ART) procedures.

Audacity IB served as exclusive sell-side financial advisor to the Company in connection with the transaction, which was announced by CooperSurgical on June 10, 2024. Nixon Peabody LLP served as legal advisor to ZyMōt Fertility. The terms of the transaction were not disclosed.

Leveraging exclusively licensed technologies developed in the Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs) at Stanford University School of Medicine and Brigham & Women's Hospital, ZyMōt Sperm Separation Devices use a patented approach to separate motile sperm from non-motile sperm in a semen sample. Alongside CooperSurgical’s comprehensive portfolio of fertility solutions, digital services, and cutting-edge ART media that supports every step in the ART journey, ZyMōt Fertility will equip more clinics around the world with the innovative technologies of today’s industry to conceive healthy babies.

“We are very proud of this transaction and the ZyMōt Fertility team. CooperSurgical is the ideal partner for our client, and we are excited about what lies ahead for ZyMōt Fertility as it begins its next phase of growth as a CooperSurgical company. It was a great pleasure working with all parties involved and being part of ZyMōt Fertility’s immensely entrepreneurial team,” said Jeffrey Shippy, Founder and CEO of Audacity IB.

“This is a truly transformational transaction for the fertility industry, and we are excited to have ZyMōt Fertility join the CooperSurgical family. Audacity did an incredible job, not only in representing us throughout the selling process; but, in working with us daily for many intense months prior to the sale, to help us build operations and accelerate growth well before the company was sold. Finding a quality, trustworthy M&A investment banker capable of also effectively serving in the trenches with a founder as a trusted long-term co-executive partner is very rare,” said William Sharp, Founder and CEO of ZyMōt Fertility.

The above announcement on the ZyMōt Fertility/CooperSurgical transaction was originally posted by Audacity IB on June 12, 2024.

ABOUT AUDACITY IB:

With offices in Los Angeles and Silicon Valley, Audacity IB provides M&A advisory, capital raising, and growth-to-exit strategic guidance for high-complexity founder-owned businesses being reshaped by innovation - spanning advanced manufacturing, automation, robotics, laser optics, medical devices, sustainable foods, specialty materials, dual-use innovation, space and defense tech, and hard and soft AI-enabled industry systems. Audacity IB is the trade name for Audacity Consulting Partners LLC and Audacity Capital Partners LLC. “Audacity IB”, “Audacity” or the “firm” refer to these two affiliated companies. Securities are offered through Audacity Capital Partners LLC, Member FINRA/SIPC. For more information, please visit www.audacityib.com.

ABOUT THE M&A ADVISOR

Founded in 1998, The M&A Advisor provides data, insight, and events for professionals working in mergers and acquisitions, restructuring, and corporate finance. Now in its 27th year, it remains the leading global network for dealmakers, helping firms stay informed, build relationships, and get recognized for their work. For information or to register for the 2025 Leadership in Dealmaking Summit, PLEASE CLICK HERE.

“Although this Award spotlights the sell-side M&A advisors, the achievement reflects the collective efforts of everyone involved - buy-side, sell-side, the founders, and management, working together to make it a success," said Jeffrey Shippy, Audacity IB

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.